Advertisement

Related Videos

Varsha Gandhi, PhD, on Ibrutinib

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

David A. Hyman, MD, JD, on Inclusive Shared Savings

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Advertisement

Advertisement




Oct
27
Today In Oncology
Divarasib in Previously Treated Advanced KRAS G12C–Mutated NSCLC
Immunotherapy/PARP Inhibitor Combination Prolongs Survival in Advanced Endometrial Cancer
Radiation Added to Systemic Therapy Improves PFS But Not OS for Oligometastatic NSCLC
Omega-3 EPA Linked to Longer Survival After Surgery for Colorectal Cancer Liver Metastases
High-Risk Melanoma Personalized mRNA Vaccine Plus Immunotherapy Reduces Risk of Recurrence After Surgery
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo